Bedaquiline reprograms central metabolism to reveal glycolytic vulnerability in Mycobacterium tuberculosis. (2020)

First Author: Mackenzie JS

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41467-020-19959-4

PubMed Identifier: 33257709

Publication URI: http://europepmc.org/abstract/MED/33257709

Type: Journal Article/Review

Volume: 11

Parent Publication: Nature communications

Issue: 1

ISSN: 2041-1723